(S (NP-SBJ (NN Phorbol) (NN ester)) (VP (VP-COOD (VP (VBZ reduces) (NP (JJ constitutive) (JJ nuclear) (NN NF) (NN kappa) (NN B))) (CC and) (VP (VBZ inhibits) (NP (NN HIV-1) (NN production)))) (PP (IN in) (NP (JJ mature) (JJ human) (JJ monocytic) (NNS cells)))) (. .))
(S (NP-SBJ-1 (NN NF) (NN kappa) (NN B)) (VP-COOD (VP (VBZ is) (NP-PRD (NP (DT a) (JJ potent) (NN mediator)) (PP (IN of) (NP (NP (JJ specific) (NN gene) (NN expression)) (PP (IN in) (NP (JJ human) (NNS monocytes))))))) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (DT the) (NN HIV-1) (NN genome)) (PP (IN in) (NP (JJ promonocytic) (NNS leukemias)))))))))))))) (. .))
(S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (NP (JJ little) (NN information)) (ADJP (JJ available)) (PP (IN on) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (NN NF) (NN kappa) (NN B))) (PP (TO to) (NP (NNS cytokines))) (PP (IN in) (NP (JJ normal) (JJ human) (NNS monocytes))))))) (. .))
(S (NP-SBJ-2 (PRP We)) (VP (VBP have) (VP (VBN used) (NP (NP (DT a) (JJ 32P-labeled) (NN oligonucleotide)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (JJ long) (JJ terminal) (NN repeat)) (, ,) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ (-NONE- *T*-3)) (VP (VBZ contains) (NP (NP (DT a) (JJ tandem) (NN repeat)) (PP (IN of) (NP (DT the) (NN NF) (NN kappa) (NN B) (NN binding) (NN sequence))))))) (, ,))))) (PP (IN as) (NP (DT a) (NN probe))) (PP (IN in) (NP (DT a) (NN gel) (NN retardation) (NN assay)))) (S (NP-SBJ (-NONE- *-2)) (VP (TO to) (VP (VB study) (NP (DT this) (NN transcription) (NN factor)))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *-4)) (VP (VBG Using) (NP (DT this) (NN assay)))) (, ,) (NP-SBJ-4 (PRP we)) (VP (VBP have) (VP (VBN detected) (NP (NN NF) (NN kappa) (NN B)) (PP (IN in) (NP (NP (NNS extracts)) (PP (IN of) (NP (NP (NNS nuclei)) (PP (IN from) (NP (JJ normal) (JJ human) (NNS monocytes))))))))) (. .))
(S (NP-SBJ (NP (NN Treatment)) (PP (IN of) (NP (JJ normal) (NNS monocytes))) (PP (IN with) (NP (NP (JJ 12-0-tetradecanoyl) (NN phorbol-13-acetate)) (PRN (-LRB- -LRB-) (NP (NN TPA)) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (QP (CD 4-24)) (NN h)))) (VP (VBD caused) (NP (NP (DT the) (JJ complete) (NN disappearance)) (PP (IN of) (NP (NN NF) (NN kappa) (NN B))) (PP (IN from) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (NNS monocytes))))))) (. .))
(S (NP-SBJ-5 (DT A) (JJ similar) (NN result)) (VP (VBD was) (VP (VBN obtained) (NP (-NONE- *-5)) (PP (IN with) (NP (DT the) (JJ mature) (JJ monocytic) (NN leukemia) (NN cell) (NN line) (NN THP-1))))) (. .))
(S (NP-SBJ-6 (DT The) (JJ constitutive) (NN transcription) (NN factor) (NN SP1)) (VP (VBD was) (VP (JJ unaffected) (NP (-NONE- *-6)) (PP (IN by) (NP-LGS (NP (NN addition)) (PP (IN of) (NP (NN TPA))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN disappearance)) (PP (IN of) (NP (NN NF) (NN kappa) (NN B))) (PP (IN from) (NP (DT the) (NN nucleus)))) (VP (VBD was) (ADJP-PRD (NP (NN concentration)) (JJ dependent)) (PP (IN between) (NP (NP (QP (CD 10) (CC and) (CD 50)) (NN (ml ng))) (PP (IN of) (NP (NN phorbol) (NN ester)))))) (. .))
(S (PP (IN In) (NP (NN THP-1) (NNS cells))) (, ,) (NP-SBJ (NN TPA)) (ADVP (RB also)) (VP (VBD induced) (NP (NP (DT a) (ADJP-COOD (ADJP (JJ new)) (, ,) (ADJP (JJ faster-migrating))) (NN NF) (NN kappa) (NN B) (NNS species)) (VP (RB not) (VBN induced) (NP (-NONE- *)) (PP (IN in) (NP (NNS monocytes)))))) (. .))
(S (NP-SBJ-COOD (NP (NN Protein) (NN kinase) (NN C) (NN inhibitor) (NN staurosporine)) (, ,) (CONJP (CC but) (RB not)) (NP (ADJP (JJ cyclic) (JJ nucleotide-dependent)) (NN protein) (NN kinase) (NN inhibitor) (NN HA-1004)) (, ,)) (ADVP (RB also)) (ADVP (RB dramatically)) (VP (VBD reduced) (NP (NP (JJ constitutive) (NNS levels)) (PP (IN of) (NP (JJ nuclear) (NN NF) (NN kappa) (NN B))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP-SBJ (NP (NN TPA) (NN addition)) (PP (TO to) (NP (NP (NNS monocytes)) (VP (VBN infected) (NP (-NONE- *)) (PP (IN with) (NP (NN HIV-1))))))) (VP (VBD inhibited) (NP (NN HIV-1) (NN replication)) (, ,) (SBAR (IN as) (S (NP-SBJ-8 (-NONE- *)) (VP (VBN determined) (NP (-NONE- *-8)) (PP (IN by) (NP (JJ reverse) (NN transcriptase) (NNS assays)))))) (, ,) (PP (IN in) (NP (DT a) (JJ concentration-dependent) (NN manner)))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP-COOD (VP (VBP are) (PP (IN in) (NP (NP (JJ striking) (NN contrast)) (PP (TO to) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP-COOD (NP (JJ nuclear) (NN NF) (NN kappa) (NN B)) (CC and) (NP (NN HIV-1) (NN replication))) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN phorbol) (NNS esters))) (PP (IN in) (NP (JJ promonocytic) (NN leukemia) (NNS cells) (NP-COOD (NP (NN U937)) (CC and) (NP (NN HL-60))))))))))))) (, ,) (CC and) (VP (VBP emphasize) (NP (NP (DT the) (NN importance)) (PP (IN of) (S (NP-SBJ (-NONE- *)) (VP (VBG studying) (NP (NP (NN cytokine) (NN regulation)) (PP (IN of) (NP (NN HIV-1))) (PP (IN in) (NP (JJ normal) (NNS monocytes)))))))))) (. .))
